Icosapent ethyl is an FDA-approved medication typically prescribed to limit triglycerides in the blood.

The new analysis, published in Circulation: Cardiovascular Interventions, focused on data from more than 600 patients who participated in the COAPT trial. 

Tracking a patient's longitudinal strain and circumferential strain may improve the ability to predict their risk of heart failure later in life. 

The company hopes to expand the use of its AI platform, primarily used to treat stroke patients, so that it can make a bigger impact on patient care. 

The analysis included eight consecutive pediatric patients who underwent TMVR with the Sapien S3 valve. The median patient age was 9 years old. 

The analysis, published in JACC: Cardiovascular Imaging, included clinical data and non-contrast CT findings from more than 66,000 patients. 

Overall, the study's authors found that depression was just as likely when patients took beta-blockers or a placebo.

The World Health Organization and European Medicines Agency have both repeatedly indicated that this does not appear to be a significant issue, but the two organizations are studying the situation closely.

While Philips is offering its available resources in the fields of research and development, the ACC is sharing the knowledge and experience of its more than 50,000 members.

When treating female patients, researchers explained, physicians are less likely to think there is potential for a heart attack.